Web Exclusives

At the recent 2010 Digestive Disease Week (DDW) meeting, positive data were presented for several investigational drugs close to approval for gastrointestinal (GI) disorders, including hepatitis C virus (HCV), Crohn’s disease, irritable bowel syndrome (IBS), and constipation. 

Several new drugs, currently at advanced stages of development, were featured during the annual meeting of the American College of Cardiology (ACC) in March 2009.

A few drugs in development were featured at the Infectious Diseases Society of America (IDSA) 2009 annual meeting. Infectious disease (ID) experts warn that the ID pipeline is dying, with only few drugs currently in development. Yet, the threat of new infections is growing worldwide in the inpatient and outpatient settings.

Several new classes of drugs in the pipeline to improve glycemic control, including a rapid-acting inhalable insulin using a new technology, were featured at the 2009 annual meeting of the American Diabetes Association (ADA).

Attacking the Kidney’s Sodium Glucose Cotransporter

Inhibitors of sodium glucose cotransporter (SGLT)-2 offer an alternate way to reduce fasting glucose and hemoglobin (Hb) A1c levels, independent of acting on insulin.

Page 18 of 18
Results 171 - 175 of 175
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME